Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Tags:
Alzheimer's disease, LY2886721, Eli Lilly, MK-8931, Merck, bapineuzumab, JNJ, solanezumab, Gammagard, Baxter International
Why This Health Care Giant Can Be a Core Holding
Motley Fool
Sun, 09/29/13 - 01:56 pm
Tags:
JNJ
How Johnson & Johnson Plans to Win the Prostate Cancer Battle
Motley Fool
Sat, 09/28/13 - 11:09 am
Tags:
Zytiga, prostate cancer, JNJ
These Drug Makers Are Still Standing Strong
Seeking Alpha
Fri, 09/27/13 - 11:45 am
Tags:
Bristol-Myers Squibb, Pfizer, JNJ, Eliquis, Xarelto, bloodthinners
Endocyte says Doxil supply interruption will not affect PROCEED trial
The Fly on the Wall
Fri, 09/27/13 - 09:11 am
Tags:
Endocyte, Doxil, JNJ, drug shortages, vintafolide, clinical trials, etarfolatide, ovarian cancer
J&J warns doctors Doxil shortage will hit next month
Fierce Pharma
Thu, 09/26/13 - 02:53 pm
Tags:
Doxil, ovarian cancer, JNJ, drug shortages, Sun Pharma
A Closer Look at 4 Pharmaceutical Giants
Motley Fool
Wed, 09/25/13 - 11:02 am
Tags:
Merck, Pfizer, JNJ, GSK
Johnson & Johnson, Cardinal Health Win Pentagon Contracts
Motley Fool
Wed, 09/25/13 - 09:14 am
Tags:
Cardinal Health, JNJ, government contracts
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Tags:
Biogen Idec, AbbVie, Amgen, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Cephalon
Why This Big Pharma Is a Health Care Industry Star
Motley Fool
Tue, 09/24/13 - 10:22 am
Tags:
JNJ
Drug Development Risk #364: Poorly Run Clinical Trials
Motley Fool
Tue, 09/24/13 - 10:10 am
Tags:
R&D, clinical trials, Merck, Vertex Pharmaceuticals, Peregrine Pharmaceuticals, JNJ, Bridion
Why Can't This Company Get Its Act Together?
Motley Fool
Mon, 09/23/13 - 03:56 pm
Tags:
JNJ, recalls
J&J, FDA And Their Tussle Over Tylenol And Liver Damage
Pharmalot
Mon, 09/23/13 - 03:36 pm
Tags:
FDA, Tylenol, JNJ
The Pharmaceutical Industry's 10 Biggest R&D Budgets
Motley Fool
Mon, 09/23/13 - 12:02 pm
Tags:
R&D, Roche, Pfizer, Merck, JNJ, Novartis, Sanofi, GSK, Eli Lilly, AstraZeneca, Bristol-Myers Squibb
J&J says Stelara approved for psoriatic arthritis
Yahoo/AP
Mon, 09/23/13 - 10:57 am
Tags:
Stelara, JNJ, psoriatic arthritis
Groundbreaking Diabetes Drug Headlines Approval Bonanza
Motley Fool
Sun, 09/22/13 - 11:25 am
Tags:
diabetes, type 2 diabetes, type 1 diabetes, JNJ, inokana, Forxiga, AstraZeneca, Bristol-Myers Squibb
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
Tags:
chronic lymphocytic leukemia, Sanofi, Campath, GSK, Arzerra, Roche, Rituxan, ibrutinib, Pharmacyclics, obinutuzumab, JNJ, Genmab
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
Tags:
rheumatoid arthritis, Humira, AbbVie, Enbrel, Amgen, Remicade, Janssen, Celebrex, Pfizer, Bristol-Myers Squibb, Orencia, Cimza, UCB, Simponi, JNJ, Arthrotec, Vimovo, AstraZeneca, Kineret
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Mon, 09/16/13 - 11:48 am
Tags:
Celgene, FDA, Bristol-Myers Squibb, AbbVie, JNJ, Eli Lilly, Revlimid, Abraxane
Party drug ketamine gains steam for antidepressant use
Fierce Biotech
Mon, 09/16/13 - 11:10 am
Tags:
JNJ, ketamine, antidepressants

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.